Latest in Pharmaceutical

Dual-chamber packaging systems as a simplification factor in the supply chain

Dual-chamber packaging solutions could represent a new frontier also to package parenteral drugs, simplifying the supply chain through reconstitution, potentially making logistics more flexible and efficient, says Cecilia Bassi, Product Manager at Bormioli Pharma

Find out more

Transmission Raman Spectroscopy - access the webinar series today

Offering significant advantages for bulk, quantitative and non-destructive analysis, Transmission Raman Spectroscopy is a preferred choice for applications where surface...
See more

Pfizer gains European Commission approval for haemophilia A and B drug, Hympavzi

The subcutaneous therapeutic is the first and only anti-tissue factor pathway inhibitor approved for the treatment of haemophilia A or B, and is available in an auto-injector format

Syndax Pharmaceuticals' leukaemia drug Revuforj bags FDA approval

The therapeutic is the first and only menin inhibitor to gain FDA approval for acute relapsed or refractory acute leukaemia

AbbVie's Elahere approved for platinum-resistant ovarian cancer by the European Commission

Elahere is the first FRα-targeting antibody-drug conjugate (ADC) to be approved in Europe for platinum-resistant ovarian cancer

Merck attains $588m global license for PD-1/VEGF bispecific antibody from LaNova Medicines

The bispecific antibody is designed for oncological indications and functions by inhibiting the PD-1/PD-L1 and the VEGF/VEGFR receptor signalling pathways

Syncona launches early-stage drug development company, Slingshot Therapeutics

The novel early-stage pharmaceutical company aims to collaborate with academic institutions to bring their findings to the clinic, with their first programme centring around inflammatory disease

Accord Healthcare bolsters UK drug manufacturing capabilities with £50m Newcastle facility

The novel automated facility will allow Accord to produce therapeutics for oncological and autoimmune diseases for the UK and beyond

Novartis obtains FDA approval for CML drug, Scemblix

The TKI's approval is an important step forward for oncology patients with newly diagnosed chronic myeloid leukaemia, and was based on the results of the Phase III ASC4FIRST trial

Novel innovation enhances productivity and output for Polish pharma company

A consultative approach to service, delivery and problem solving ensured that a Polish pharmaceutical company received the equipment and technology it needed to ramp up production and expand into new geographies

Latest posts in Pharmaceutical

Quotient Sciences and Medicines for Malaria Venture announce first-ever long-acting injectable for malaria prevention

First-in-human study explores a single injection that provides 3 months of protection

Astellas' Vyloytm plus chemo gains FDA approval for gastric adenocarcinoma

The drug is the first CLDN18.2 targeted therapy to be approved in the US, and can further extend a patient's PFS and OS compared with chemotherapy alone

Novo Nordisk's haemophilia A/B drug Alhemo gets positive opinion from the EMA

The subcutaneous, self-administering prophylactic can allow a patient to produce thrombin, a clotting agent, even in the presence of inhibitors

Pfizer's haemophilia A/B therapeutic Hympavzi gains FDA approval

The pharma giant's once-weekly injectable can be administered subcutaneously and is able to significantly reduce annualised bleeding

Roche's breast cancer combination therapy Itovebi bags FDA approval

Itovebi plus palbociclib and fulvestrant reduced the risk of disease progression or death significantly in patients

AstraZeneca's Tagrisso obtains FDA approval for use in stage III NSCLC

Tagrisso reduced the risk of disease progression or death by 84% compared to placebo in the Phase III LAURA trial

Zevra Therapeutics' Miplyffa becomes the first FDA-approved therapeutic for Niemann-Pick disease

Miplyffa can now be used to treat type-C Niemann-Pick disease, a rare and progressive neurodegenerative disease

Roche's antiviral Xofluza reduces flu transmission in Phase III trial

Topline results suggest that Xofluza could be used to reduce the transmission of seasonal influenza

Genesis Pharma to distribute Santhera's Agamree for DMD

The therapeutic recently received EC approval to treat patients over 4 years old with Duchenne muscular dystrophy

CPHI Milan announces the finalists for 14 categories of the Pharma Awards

Awards for future leaders, women of the year and those at the heart of pharma will be handed out at the CPHI Pharma Awards ceremony

APL and CurifyLabs join forces to personalise medicinal administration with 3D printing

The companies will manufacture personalised medicines with specific dosages and dosage form characteristics for frail and young patients

Johnson & Johnson submits nipocalimab application to the FDA following positive Phase III results

The drug — in combination with the standard of care regimen — was able to exhibit sustained disease control over the 24 week trial period

Sponsor content

Cleancube multi: Guardtech’s container facilities support NHS aseptic pharmacies

Award-winning mobile cleanrooms offer fast, flexible solutions for facility upgrades

The importance of accurate tare/gross weighing systems in the pharmaceutical industry

Why accurate tare/gross weighing is critical in pharmaceutical settings

CPHI Milan survey 'faster CDMO growth in 2025 predicted' and 'industry not in favour of BIOSECURE Act'

49% of industry is ‘highly positive’ on contract services growth in the next 18-months

CPHI Milan analysis ‘Lombardy the best location for pharma manufacturing in Europe’

Report predicts significant growth for Lombardy’s pharma industry in 2025 as event directly contributes more than €120m to region

Biotech Capital on the rise and outsourcing to accelerate in 2025 - but uneven growth for CDMOs

European biotech recovery gains momentum as Chinese biotech declines, and IPO activity remains weak

IMA showcases pharmaceutical innovations at CPHI, Milan

Aseptic processing, continuous manufacturing, and sustainable packaging at the forefront

Thermo Fisher scientific launches iCAP MX series ICP-MS for trace elemental analysis

New platform simplifies analysis while enhancing productivity and accuracy

Sphere Fluidics unveils Cyto-Mine Chroma to enhance single-cell analysis

New platform offers multiplexing capabilities and accelerates biotherapeutic discovery and development

Marchesini Group celebrates 50 years of innovation at CPHI 2024

Showcasing a new cartoning machine model and the latest digital division technologies

Ensuring cGMP compliance in cell and gene therapy manufacturing

3P discusses how companies can scale up their CGT manufacturing protocols while remaining compliant with stringent global regulations

At Pack Expo 2024, Antares Vision Group to debut versatile, high-speed serialization station for pharma bottles of various shapes and sizes

Antares Vision Group will also introduce a serialization module for flat cartons and demonstrate a high-speed automated visual inspection unit for liquid-filled vials

What’s the difference between a factory acceptance test and site acceptance testing?

When manufacturing complex machinery in industries such as pharmaceuticals or fine chemicals, extensive equipment testing must be carried out before commissioning

Featured companies

Founded in 1949, Stevanato Group is a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life... 3P innovation is a UK-based engineering and custom automation company, delivering innovative solutions to leading major pharmaceutical and medical device companies. We support...
See more